GlassScriptPhysician profile
Duncan D Harris
NPI 1679528632
$2,979.88
in general payments reported to CMS, 2019-2025
24 companies · $747 in 2025
The $747 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $17.59 · 2021: $106 · 2022: $303 · 2023: $840 · 2024: $711 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,100 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,099.97 |
| Education | $198.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $584.54 | 2019-2025 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $558.04 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $424.20 | 2019-2025 | Lithovue, Rezum Generator |
| Janssen Biotech, INC. | $265.24 | 2023-2025 | Erleada |
| Cook Medical LLC | $254.32 | 2025 | Cook, Litho 150 |
| Pfizer INC. | $194.35 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $152.03 | 2023-2025 | Lynparza |
| Abbvie INC. | $123.49 | 2020-2025 | |
| Urovant Sciences INC | $63.49 | 2022 | |
| Coloplast Corp | $58.54 | 2021-2023 | Speedicath, Altis |
| Dendreon Pharmaceuticals LLC | $35.62 | 2023-2024 | Provenge |
| Ambu INC. | $35.21 | 2025 | |
| Progenics Pharmaceuticals, INC. | $28.34 | 2024 | |
| 180 Medical, INC. | $24.10 | 2022 | |
| Accord Healthcare, INC. | $22.22 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $20.15 | 2024 | Adstiladrin |
| Procept Biorobotics Corporation | $19.82 | 2022 | |
| Laborie Medical Technologies Corp. | $19.70 | 2023 | |
| Immunitybio, INC. | $19.37 | 2024 | |
| Amgen INC. | $19.36 | 2019 | |
| Organogenesis INC. | $16.49 | 2024 | |
| Conmed Corporation | $15.63 | 2024 | Airseal |
| Olympus America INC. | $13.03 | 2019 | |
| Urogen Pharma, INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duncan Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.